In 2022 the company made a revenue of $0.06 M a decrease over the years 2021 revenue that were of $0.19 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | N/A | -100% |
2022 | $0.06 M | -65.74% |
2021 | $0.19 M | -20.19% |
2020 | $0.23 M | -15.55% |
2019 | $0.28 M | -34.09% |
2018 | $0.42 M | 30.51% |
2017 | $0.32 M | 46.95% |
2016 | $0.22 M | 6.65% |
2015 | $0.21 M | 11.02% |
2014 | $0.18 M | 9358.97% |
2013 | $0 M | |
2012 | N/A | |
2011 | N/A | |
2010 | N/A | |
2009 | N/A |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
Becton Dickinson BDX | $19.49 B | N/A | ๐บ๐ธ USA |
Utah Medical Products UTMD | $50.22 M | N/A | ๐บ๐ธ USA |
Emergent BioSolutions
EBS | $1.02 B | N/A | ๐บ๐ธ USA |